Toggle navigation
Home
Search
Services
Blog
Contact
About
Monoclone Antibodies Against Progestin Receptor Isoforms
Anderson, Thomas R.
Berkeley Antibody Company, Richmond, CA, United States
Search 127 grants from Thomas Anderson
Search grants from Berkeley Antibody Company
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
BCR Signaling in ABC DLBCL
The role of the innate immune system on Treg reprogramming in human autoimmune di
Enzyme Catalysis &Bridged Bi-Metal Motif
DNA Damage Response in Eukaryotic Cells
Nanoparticle-directed synthesis of organic nanorods
Recently added grants:
Uz-Ucsf Ctu
AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery
Rational design and B cell responses of HIV epitope vaccines
Viral and Host Determinants of Chikungunya Virus Dissemination
CELL TYPE-SPECIFIC CONTROL of GENE EXPRESSION by RIBOSOMAL PROTEIN ISOFORMS
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43DK012277-001
Application #
3637978
Study Section
Project Start
1991-08-01
Project End
1992-04-30
Budget Start
1992-03-26
Budget End
1992-01-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Berkeley Antibody Company
Department
Type
DUNS #
City
Richmond
State
CA
Country
United States
Zip Code
94806
Related projects
NIH 1992
N43 DK
Monoclone Antibodies Against Progestin Receptor Isoforms
Anderson, Thomas R. / Berkeley Antibody Company
NIH 1991
N43 DK
Monoclone Antibodies Against Progestin Receptor Isoforms
Anderson, Thomas R. / Berkeley Antibody Company
Comments
Be the first to comment on Thomas Anderson's grant